AAAAAA
Results: 26-39/39
Authors:
PIRMOHAMED M
KITTERINGHAM NR
QUEST LJ
ALLOTT RL
GREEN VJ
GILMORE IT
PARK BK
Citation: M. Pirmohamed et al., GENETIC-POLYMORPHISM OF CYTOCHROME P4502E1 AND RISK OF ALCOHOLIC LIVER-DISEASE IN CAUCASIANS, Pharmacogenetics, 5(6), 1995, pp. 351-357
Authors:
GREEN VJ
PIRMOHAMED M
KITTERINGHAM NR
KNAPP MJ
PARK BK
Citation: Vj. Green et al., GLUTATHIONE-S-TRANSFERASE-MU GENOTYPE (GSTM1-ASTERISK-0) IN ALZHEIMERS PATIENTS WITH TACRINE TRANSAMINITIS, British journal of clinical pharmacology, 39(4), 1995, pp. 411-415
Authors:
PARK BK
PIRMOHAMED M
KITTERINGHAM NR
Citation: Bk. Park et al., THE ROLE OF CYTOCHROME-P450 ENZYMES IN HEPATIC AND EXTRAHEPATIC HUMANDRUG TOXICITY, Pharmacology & therapeutics, 68(3), 1995, pp. 385-424
Authors:
PIRMOHAMED M
MARTIN U
Citation: M. Pirmohamed et U. Martin, CONFERENCE REPORTS - THERAPEUTICS 1995 - ABSTRACTS, Journal of the Royal College of Physicians of London, 29(6), 1995, pp. 530-534
Authors:
MAGGS JL
WILLIAMS D
PIRMOHAMED M
PARK BK
Citation: Jl. Maggs et al., THE METABOLIC FORMATION OF REACTIVE INTERMEDIATES FROM CLOZAPINE, A DRUG-ASSOCIATED WITH AGRANULOCYTOSIS IN MAN, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1463-1475
Authors:
PIRMOHAMED M
WILLIAMS D
MADDEN S
TEMPLETON E
PARK BK
Citation: M. Pirmohamed et al., METABOLISM AND BIOACTIVATION OF CLOZAPINE BY HUMAN LIVER IN-VITRO, The Journal of pharmacology and experimental therapeutics, 272(3), 1995, pp. 984-990
Authors:
GREEN VJ
PIRMOHAMED M
KITTERINGHAM NR
GAEDIGK A
GRANT DM
BOXER M
BURCHELL B
PARK BK
Citation: Vj. Green et al., GENETIC-ANALYSIS OF MICROSOMAL EPOXIDE HYDROLASE IN PATIENTS WITH CARBAMAZEPINE HYPERSENSITIVITY, Biochemical pharmacology, 50(9), 1995, pp. 1353-1359
Authors:
DAVIS CD
PIRMOHAMED M
KITTERINGHAM NR
ALLOTT RL
SMITH D
PARK BK
Citation: Cd. Davis et al., KINETIC-PARAMETERS OF LYMPHOCYTE MICROSOMAL EPOXIDE HYDROLASE IN CARBAMAZEPINE HYPERSENSITIVE PATIENTS - ASSESSMENT BY RADIOMETRIC HPLC, Biochemical pharmacology, 50(9), 1995, pp. 1361-1366
Authors:
PARK BK
PIRMOHAMED M
TINGLE MD
MADDEN S
KITTERINGHAM NR
Citation: Bk. Park et al., BIOACTIVATION AND BIOINACTIVATION OF DRUGS AND DRUG METABOLITES - RELEVANCE TO ADVERSE DRUG-REACTIONS, Toxicology in vitro, 8(4), 1994, pp. 613-621
Authors:
PIRMOHAMED M
ALLOTT R
GREEN VJ
KITTERINGHAM NR
CHADWICK D
PARK BK
Citation: M. Pirmohamed et al., LYMPHOCYTE MICROSOMAL EPOXIDE HYDROLASE IN PATIENTS ON CARBAMAZEPINE THERAPY, British journal of clinical pharmacology, 37(6), 1994, pp. 577-581
Authors:
PIRMOHAMED M
QUEST LJ
KITTERINGHAM NR
ALLOTT RA
GILMORE IT
PARK BK
Citation: M. Pirmohamed et al., ASSOCIATION BETWEEN CYTOCHROME-P450-2E1 (CYP2E1) RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND ALCOHOLIC LIVER-DISEASE IN CAUCASIANS, Hepatology, 20(4), 1994, pp. 10000317-10000317
Authors:
PIRMOHAMED M
KITTERINGHAM NR
PARK BK
Citation: M. Pirmohamed et al., THE ROLE OF ACTIVE METABOLITES IN DRUG TOXICITY, Drug safety, 11(2), 1994, pp. 114-144
Authors:
FRIEDMANN PS
STRICKLAND I
PIRMOHAMED M
PARK BK
Citation: Ps. Friedmann et al., INVESTIGATION OF MECHANISMS IN TOXIC EPIDERMAL NECROLYSIS INDUCED BY CARBAMAZEPINE, Archives of dermatology, 130(5), 1994, pp. 598-604
Authors:
TINGLE MD
PIRMOHAMED M
TEMPLETON E
WILSON AS
MADDEN S
KITTERINGHAM NR
PARK BK
Citation: Md. Tingle et al., AN INVESTIGATION OF THE FORMATION OF CYTOTOXIC, GENOTOXIC, PROTEIN-REACTIVE AND STABLE METABOLITES FROM NAPHTHALENE BY HUMAN LIVER-MICROSOMES, Biochemical pharmacology, 46(9), 1993, pp. 1529-1538